| A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients (NCT05659602) | Beijing Ditan Hospital | 2022-07-09 |
| Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients (NCT05364671) | Materia Medica Holding | 2022-04-29 |
| A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults (NCT05184062) | AstraZeneca | 2021-12-03 |
| A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults (NCT05437289) | AstraZeneca | 2021-10-09 |
| COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older (NCT04848467) | Bayer | 2021-10-01 |
| Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222 (NCT04877743) | AstraZeneca | 2021-05-31 |
| COVID-19 and Anti-CD14 Treatment Trial (NCT04391309) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-04-12 |
| Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects (NCT04638634) | CSL Behring | 2021-02-02 |
| Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19) (NCT04644120) | AbbVie | 2020-12-10 |
| Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans (NCT04649515) | Tychan Pte Ltd. | 2020-12-04 |
| COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C (NCT04588363) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-11-19 |
| A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects (NCT04516564) | Akesobio Australia Pty Ltd | 2020-09-28 |
| Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19. (NCT04395170) | Lifefactors Zona Franca, SAS | 2020-09-01 |
| CSL324 in COVID-19 (NCT04519424) | CSL Behring | 2020-09-01 |
| A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection (NCT04508023) | Janssen Research & Development, LLC | 2020-08-13 |
| Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects (NCT04483375) | Sinocelltech Ltd. | 2020-07-24 |
| Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure (NCT04389840) | Jazz Pharmaceuticals | 2020-07-08 |
| Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009) (NCT04425733) | Merck Sharp & Dohme LLC | 2020-07-07 |
| Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers (NCT04438837) | Rambam Health Care Campus | 2020-07-01 |
| Safety of TY027, a Treatment for COVID-19, in Humans (NCT04429529) | Tychan Pte Ltd. | 2020-06-09 |
| Collection of Anti-SARS-CoV-2 Immune Plasma (NCT04344977) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-06-01 |
| Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. (NCT04374526) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-05-27 |
| Immunophenotyping Assessment in a COVID-19 Cohort (NCT04378777) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-05-01 |
| COVID-19: Human Epidemiology and Response to SARS-CoV-2 (NCT04375761) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-05-01 |
| Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) (NCT04317040) | Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2020-04-24 |
| Evaluation of Silver Nanoparticles for the Prevention of COVID-19 (NCT04894409) | Cluster de Bioeconomia de Baja California, A.C | 2020-04-24 |
| Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency (NCT04403932) | Hospital San Carlos, Madrid | 2020-04-17 |
| Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) (NCT04341116) | I-Mab Biopharma US Limited | 2020-04-11 |
| Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 (NCT04473170) | Abu Dhabi Stem Cells Center | 2020-04-04 |
| Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19) (NCT04346368) | Guangzhou Institute of Respiratory Disease | 2020-04-01 |
| BCG Vaccination to Protect Healthcare Workers Against COVID-19 (NCT04327206) | Murdoch Childrens Research Institute | 2020-03-30 |
| Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia (NCT04275245) | Tang-Du Hospital | 2020-02-03 |